TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News

Tech Stocks
TSX Today: What to Watch for in Stocks on Thursday, April 7

Cannabis Stocks
Why Tilray Stock Skyrocketed 54% Last Week

Cannabis Stocks
Why Cannabis Stocks Dropped 10% on Monday

Cannabis Stocks
Here’s Why Cannabis Stocks SURGED Last Week

Investing
TSX Today: What to Watch for in Stocks on Monday, March 28

Cannabis Stocks
Why Tilray Stock Jumped 36% on Thursday

Investing
3 TSX Stocks Primed for a Breakout in the Near Future

Cannabis Stocks
Tilray Partners With Hexo: What You Should Know

Cannabis Stocks
Why Cannabis Stocks Should Be on the Top of Your Buy List

Investing
3 Underperforming Canadian Stocks to Buy Right Now

Cannabis Stocks
Launching of JV Could See 2 Weed Stocks Soar 50%
